Neue Studie belegt Behandlungslücke bei Osteoporose: Zwei von drei Schweizerinnen über 70 Jahre trotz erhöhtem Frakturrisiko unbehandelt

SPECIAL REPORT

Rheumatoid Arthritis

EULAR 2021

Rheumatoid Arthritis

Patienten mit rheumatoider Arthritis profitieren von bewährter Therapie

Dieser Artikel wurde von Bristol-Myers Squibb SA unterstützt

SPECIAL REPORT

Further Publications Immunology

Wiederkehrende Schwellungen der Haut, Schleimhäute und an inneren Organen

COMMENTED

Systemic Sclerosis

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)

★ 3 Recommended and commented by Dr Heino Prillwitz, Faculty Member

Arthritis Res Ther.

Pan Z, Marra AM, Benjamin N, Eichstaedt CA, Blank N, Bossone E, Cittadini A, Coghlan G, Denton CP, Distler O, Egenlauf B, Fischer C, Harutyunova S, Xanthouli P, Lorenz HM, Grünig E

doi: 10.1186/s13075-019-1981-0.

COMMENTED

Melanoma and Skin Cancer

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

J Am Acad Dermatol.

Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A

doi: 10.1016/j.jaad.2017.11.042.

COMMENTED

Gout

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study

Arthritis Rheumatol.

Saag KG, Becker MA, Whelton A, Hunt B, Castillo M, Kisfalvi K, Gunawardhana L

doi: 10.1002/art.40685.

COMMENTED

Psoriatic Arthritis

Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5

★ 3 Recommended and commented by Dr Heino Prillwitz, Faculty Member

Rheumatology (Oxford).

van der Heijde D, Mease PJ, Landewé RBM, Rahman P, Tahir H, Singhal A, Boettcher E, Navarra S, Zhu X, Ligozio G, Readie A, Mpofu S, Pricop L

doi: 10.1093/rheumatology/kez420.

COMMENTED

A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia

J Dermatolog Treat.

Rossi A, Campo D, Fortuna MC, Garelli V, Pranteda G, De Vita G, Sorriso-Valvo L, Di Nunno D, Carlesimo M

doi: 10.1080/

SPECIAL INTERVIEW

Psoriatic ArthritisRheumatoid ArthritisSpinal Disorders

Related content

EULAR 2021

Patienten mit rheumatoider Arthritis profitieren von bewährter Therapie

Wiederkehrende Schwellungen der Haut, Schleimhäute und an inneren Organen

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study

Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5

A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia

«Der Switch vom Originalpräparat auf BenepaliTM ist aus meiner Sicht problemlos möglich»

«Der Switch vom Originalpräparat auf Benepali^TM ist aus meiner Sicht problemlos möglich»